This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Tunitas Therapeutics, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Nolan Sigal
Introduction
Nolan Sigal is a prominent inventor based in Los Altos, CA. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of 2 patents, Sigal's work focuses on advancing medical treatments and understanding biological responses.
Latest Patents
One of his latest patents is the Epsigam fusion protein. This novel fusion protein has the ability to cross-link either of the FcεRI or FcεRII cell surface receptors with an FcγRIIb cell surface receptor. This mechanism is designed to block IgE-mediated biological responses, showcasing Sigal's commitment to addressing complex medical challenges.
Career Highlights
Nolan Sigal is currently associated with Tunitas Therapeutics, Inc., where he continues to push the boundaries of innovation in therapeutic development. His work at Tunitas Therapeutics reflects his dedication to improving patient outcomes through scientific advancements.
Collaborations
Sigal collaborates with various professionals in the field, including his coworker Gizette Sperinde. These collaborations enhance the research and development efforts at Tunitas Therapeutics, fostering an environment of innovation.
Conclusion
Nolan Sigal's contributions to biotechnology through his patents and work at Tunitas Therapeutics, Inc. highlight his role as a key innovator in the field. His efforts in developing the Epsigam fusion protein exemplify the impact of his work on medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile